US 12,138,380 B2
Negative-pressure therapy with pneumatically-actuated instillation
Benjamin Andrew Pratt, Poole (GB); Christopher Brian Locke, Bournemouth (GB); and James Killingworth Seddon, Wimborne (GB)
Assigned to Solventum Intellectual Properties Company, Maplewood, MN (US)
Filed by Solventum Intellectual Properties Company, Maplewood, MN (US)
Filed on Aug. 10, 2021, as Appl. No. 17/398,671.
Application 17/398,671 is a continuation of application No. 15/520,360, granted, now 11,135,342, previously published as PCT/US2015/057240, filed on Oct. 23, 2015.
Claims priority of provisional application 62/068,425, filed on Oct. 24, 2014.
Prior Publication US 2022/0001094 A1, Jan. 6, 2022
Int. Cl. A61M 1/00 (2006.01); A61F 13/05 (2024.01)
CPC A61M 1/85 (2021.05) [A61F 13/05 (2024.01); A61M 1/772 (2021.05); A61M 1/92 (2021.05); A61M 1/964 (2021.05); A61M 1/96 (2021.05); A61M 2205/0216 (2013.01); A61M 2205/3337 (2013.01)] 15 Claims
OG exemplary drawing
 
1. An apparatus for managing fluid in a system for negative-pressure therapy, the apparatus comprising:
a container housing having an interior configured to be coupled to a negative-pressure source;
an instillation regulator configured to be fluidly coupled to an instillation solution source, the instillation regulator comprising:
a solution outlet port;
a solution inlet port; and
a negative-pressure port;
a panel configured to be coupled to the container housing to enclose the instillation regulator and to form an exudate container, wherein the panel comprises:
a first side configured to face the container housing;
a second side opposite the first side;
a channel formed in the second side of the panel;
a first passage through the panel; and
a second passage through the panel; and
a seal configured to be attached to the second side of the panel to cover the channel and form an integrated fluid conductor.